Using stem cells in multiple sclerosis therapies

References

• Muraro PA, Cassiani Ingoni R, Martin R. Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges. Curr Opin Neurol 2003;16:299–305.
   PubMed Web of Science ®Google Scholar
• Fassas A, Kimiskidis VK. Stem cell transplantation for multiple sclerosis: what is the evidence? Blood Rev 2003;17:233–40.
   PubMed Web of Science ®Google Scholar
• Saccardi R, Mancardi G, Di Bartolomeo P et al. Immunoablation followed by stem cell rescue in refractory multiple sclerosis: long-term follow-up of MRI and quality of life. Bone Marrow Transplant 2004;33 (Suppl 1):525.
   Google Scholar
• Carreras E, Saiz A, Mann P et al. CD34± selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003;88:306–14.
   PubMed Web of Science ®Google Scholar
• Saiz A, Carreras E, Berenguer J et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS. Neurology 2001;56:1084–9.
   PubMed Web of Science ®Google Scholar
• Inglese M, Mancardi GL, Pagani E et al. Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. 7 Neurol Neurosurg Psychiany 2004;75:643–4.
   PubMed Web of Science ®Google Scholar
• Nash RA, Bowen JD, McSweeney PA et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 2003;102:2364— 72.
   PubMedGoogle Scholar
• Kurtzke JE Rating neurologic impairment in multiple sclerosis: an expanded disability status scale. Neurology 1983;33:1444— 52.
   PubMed Web of Science ®Google Scholar
• Burt RK, Cohen BA, Russell E et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 2003;102:2373— 8.
   PubMedGoogle Scholar
• Brodsky RA, Petri M, Smith BD et al. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med 1998;129:1031–5.
   PubMed Web of Science ®Google Scholar
• Burt RK, Cohen B, Stefoski D et al. Non-myeloablative hematopoietic stem cell transplantation for multiple sclerosis. Arch Neurol (accepted for publication).
   Google Scholar
• Karussis D, Slavin S. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the proce-dures. 7 Neurol Sci 2004;223:59–64.
   PubMed Web of Science ®Google Scholar
• Allen IV, McQuaid S, Mirakhur M, Nevin G. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci 2001;22:141–4.
   PubMed Web of Science ®Google Scholar
• Grigoriadis N, Ben-Hur T, Karussis D, Milonas I. Axonal damage in multiple sclerosis: a complex issue in a complex disease. Clin Neurol Neurosurg 2004;106:211 — 7.
   PubMed Web of Science ®Google Scholar
• Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multi-ple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001;7:115–21.
   Google Scholar
• Coleman MP, Perry VH. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 2002;25:532— 7.
   PubMed Web of Science ®Google Scholar
• Sobeih MM, Corfas G. Extracellular factors that regulate neuronal migration in the central nervous system. Int 7 Dev Neurosci 2002;20:349— 57.
   PubMed Web of Science ®Google Scholar
• Pearse DD, Pereira FC, Marcillo AE et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 2004;10:610–6.
   PubMed Web of Science ®Google Scholar
• Pluchino S, Furlan R, Martino G. Cell-based remyelinating therapies in multiple sclerosis: evidence from experimental studies. Curr Opin Neurol 2004;17:247— 55.
   Google Scholar
• Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote exten-sive host axonal growth after spinal cord injury Exp Neurol 2003;181:115–29.
   Google Scholar
• Luo Y, Cai J, Liu Y et al. Microarray analysis of selected genes in neural stem and progenitor cells. 7 Neurochent 2002;83:1481–97.
   PubMed Web of Science ®Google Scholar
• Chu K, Kim M, Jeong SW, Kim SU, Yoon BW. Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurarci Lett 2003;343:129— 33.
   Google Scholar
• Karnezis T, Mandemakers W, McQualter JL et al. The neuriteoutgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosti 2004;7:736–44.
   PubMed Web of Science ®Google Scholar